Growth Metrics

Rockwell Medical (RMTI) Accumulated Expenses (2016 - 2026)

Rockwell Medical filings provide 16 years of Accumulated Expenses readings, the most recent being $4.3 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 30.88% to $4.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 30.88% decrease, with the full-year FY2025 number at $4.3 million, down 30.88% from a year prior.
  • Accumulated Expenses hit $4.3 million in Q4 2025 for Rockwell Medical, up from $3.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $7.7 million in Q4 2022 to a low of $3.8 million in Q2 2023.
  • Median Accumulated Expenses over the past 5 years was $4.6 million (2022), compared with a mean of $5.1 million.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 63.91% in 2024 and later crashed 38.55% in 2025.
  • Rockwell Medical's Accumulated Expenses stood at $5.1 million in 2021, then soared by 51.32% to $7.7 million in 2022, then decreased by 7.18% to $7.1 million in 2023, then decreased by 12.23% to $6.3 million in 2024, then tumbled by 30.88% to $4.3 million in 2025.
  • The last three reported values for Accumulated Expenses were $4.3 million (Q4 2025), $3.9 million (Q3 2025), and $4.1 million (Q2 2025) per Business Quant data.